España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
IDEAYA Biosciences
IDYA
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$33.29
-0.43
-1.28%
At Close: -
$33.29
0
0.00%
After Hours: 1:02 PM EDT
15 minutes delayed
Get Report
Watch
IDEAYA Biosciences (IDYA) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for IDEAYA Biosciences (NASDAQ:IDYA) Stock
IDEAYA Biosciences Stock (NASDAQ: IDYA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, June 25, 2024
Ideaya Biosciences Has Dosed Its First Patien...
Benzinga Newsdesk
Monday, June 24, 2024
Ideaya Biosciences Announced Clinical Program...
Benzinga Newsdesk
Tuesday, June 04, 2024
Stifel Maintains Buy on IDEAYA Biosciences, R...
Benzinga Newsdesk
Monday, June 03, 2024
IDEAYA Biosciences shares are trading higher ...
Benzinga Newsdesk
IDEAYA Biosciences Shares Phase 2 Results for...
Benzinga Newsdesk
Monday, May 13, 2024
Goldman Sachs Maintains Buy on IDEAYA Bioscie...
Benzinga Newsdesk
Wednesday, May 08, 2024
Unveiling 5 Analyst Insights On IDEAYA Biosciences
Benzinga Insights
Wedbush Reiterates Outperform on IDEAYA Biosc...
Benzinga Newsdesk
Tuesday, May 07, 2024
IDEAYA Biosciences Says $941.4M Of Cash, Cash...
Benzinga Newsdesk
IDEAYA Biosciences Q1 2024 GAAP EPS $(0.53), ...
Benzinga Newsdesk
Wednesday, April 24, 2024
IDEAYA Biosciences Announces ASCO 2024 Oral P...
Benzinga Newsdesk
Monday, April 22, 2024
IDEAYA Biosciences Has Selected Move-Forward ...
Benzinga Newsdesk
Thursday, March 21, 2024
Citigroup Maintains Buy on IDEAYA Biosciences...
Benzinga Newsdesk
Tuesday, March 12, 2024
Ideaya Biosciences Has Entered Into A Clinica...
Benzinga Newsdesk
Friday, March 08, 2024
Demystifying IDEAYA Biosciences: Insights From 6 Analyst Reviews
Benzinga Insights
BTIG Initiates Coverage On IDEAYA Biosciences...
Benzinga Newsdesk
Wednesday, February 21, 2024
The Analyst Verdict: IDEAYA Biosciences In The Eyes Of 6 Experts
Benzinga Insights
RBC Capital Maintains Outperform on IDEAYA Bi...
Benzinga Newsdesk
Tuesday, February 20, 2024
Recap: IDEAYA Biosciences Q4 Earnings
Benzinga Insights
IDEAYA Biosciences' Cash Balance As Of Decemb...
Benzinga Newsdesk
IDEAYA Biosciences Q4 EPS $(0.52) Misses $(0....
Benzinga Newsdesk
Friday, January 26, 2024
The Analyst Verdict: IDEAYA Biosciences In The Eyes Of 8 Experts
Benzinga Insights
Goldman Sachs Maintains Buy on IDEAYA Bioscie...
Benzinga Newsdesk
Thursday, January 25, 2024
Goldman Sachs Maintains Buy Rating for IDEAYA Biosciences: Here's What You Need To Know
Benzinga Insights
Goldman Sachs Maintains Buy on IDEAYA Bioscie...
Benzinga Newsdesk
Saturday, January 20, 2024
Announced Late Friday: On January 19, 2024, Ideaya Biosciences Entered Into An Open Market Sales Agreement With Jefferies, Under Which The Company May Offer And Sell Shares Of Its Common Stock With Aggregate Gross Proceeds Of Up To $350M
Charles Gross
Friday, January 12, 2024
Ideaya Biosciences Said From Jan 4 To Jan 11, Sold 4.6M Shares For Net Proceeds Of $158.9M Under At-The-Market Offering Pursuant To June 2023 Agreement
Charles Gross
Wednesday, January 10, 2024
Critical Insights From IDEAYA Biosciences Analyst Ratings: What You Need To Know
Benzinga Insights
RBC Capital Maintains Outperform on IDEAYA Bi...
Benzinga Newsdesk
Sunday, January 07, 2024
IDEAYA Biosciences Says Balance Sheet Of $511...
Benzinga Newsdesk
Wednesday, December 06, 2023
RBC Capital Reiterates Outperform on IDEAYA B...
Benzinga Newsdesk
Monday, December 04, 2023
Ideaya Biosciences Announced A Clinical Study...
Benzinga Newsdesk
Thursday, November 30, 2023
8 Analysts Have This to Say About IDEAYA Biosciences
Benzinga Insights
JP Morgan Maintains Overweight on IDEAYA Bios...
Benzinga Newsdesk
Monday, November 13, 2023
The Latest Analyst Ratings for IDEAYA Biosciences
Benzinga Insights
Wedbush Reiterates Outperform on IDEAYA Biosc...
Benzinga Newsdesk
Wednesday, November 08, 2023
Guggenheim Maintains Buy on IDEAYA Bioscience...
Benzinga Newsdesk
Wedbush Reiterates Outperform on IDEAYA Biosc...
Benzinga Newsdesk
Tuesday, November 07, 2023
IDEAYA Biosciences Q3 EPS $(0.46) Beats $(0.4...
Benzinga Newsdesk
Wednesday, October 25, 2023
Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
Why IDEAYA Biosciences Stock Is Falling During Wednesday's Session
Henry Khederian
IDEAYA shares are trading lower after the com...
Benzinga Newsdesk
Alphabet, Texas Instruments, CoStar Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Lisa Levin
Tuesday, October 24, 2023
IDEAYA shares are trading lower after the com...
Benzinga Newsdesk
IDEAYA Intends To Offer And Sell Up To $125M ...
Benzinga Newsdesk
RBC Capital Maintains Outperform on IDEAYA Bi...
Benzinga Newsdesk
Monday, October 23, 2023
IDEAYA Biosciences Announced Development Cand...
Benzinga Newsdesk
Tuesday, October 17, 2023
IDEAYA Biosciences shares are trading higher ...
Benzinga Newsdesk
Ideaya Biosciences Announces The Publication ...
Benzinga Newsdesk
Monday, October 16, 2023
Ideaya Biosciences Has Initiated A Phase 2 Ex...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch